Healthcare / Drug Manufacturers - GeneralUpdated 2026-05-10 22:07 UTC

GRFS stock hub

Grifols, S.A. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

GRFSis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

6.5B

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

GRFS

In the news

Latest news · GRFS

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E8.5

P25 12.3P50 18.4P75 33.1

Trailing P/E13.7

P25 14.9P50 23.2P75 38.5

ROE6.1

P25 -105.6P50 -46.5P75 -3.1

ROIC6.7

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All GRFS market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

251

Groups with data

Currency

EUR

Showing 251 of 251 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001438569
Company name	Grifols, S.A.
Country	Spain
Country code	US
Cusip	398438408
Employees	25,247
Employees Change	1,425%
Employees Change Percent	5.98
Enterprise value	$19.9B
Exchange	NASDAQ
Financial currency	EUR
First seen	2026-05-09
Industry	Drug Manufacturers - General
IPO Date	2006-05-17
Isin	US3984384087
Last refreshed	2026-05-10
Market cap	$6.5B
Market cap category	Mid-Cap
Price	$8.08
Price currency	USD
Rev Per Employee	339,685.53x
Sector	Healthcare
Sic	2834
Symbol	GRFS
Website	https://www.grifols.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	7.32%
EV Earnings	41.6x
EV Sales Forward	5.3x
EV/EBIT	12.49x
EV/EBITDA	10.3x
EV/FCF	22.41x
EV/Sales	2.32x
FCF yield	13.58%
Forward P/E	8.55x
P/B ratio	0.72x
P/E ratio	13.66x
P/S ratio	0.76x
PE Ratio10 Y	46.3x
PE Ratio3 Y	69.86x
PE Ratio5 Y	69.05x
PS Forward	1.74x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	18.58%
EBITDA Margin	22.54%
FCF margin	10.35%
Gross margin	38.36%
Gross Profit	$3.3B
Gross Profit Growth	-1.74%
Gross Profit Growth Q	-9.31%
Gross Profit Growth3 Y	7.59%
Gross Profit Growth5 Y	5.36%
Net Income	$478.5M
Net Income Growth	112.57%
Net Income Growth Q	22.23%
Net Income Growth Years	2%
Net Income Growth3 Y	107.13%
Net Income Growth5 Y	-5.89%
Pretax Margin	8.21%
Profit Margin	5.58%
Profit Per Employee	$18,953
Profitable Years	18
ROA	4.21
Roa5y	2.87
ROCE	7.7
ROE	6.13
Roe5y	3.59
ROIC	6.74
Roic5y	4.16

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-4.95%
Cagr1y	11.89%
Cagr3y	3.25%
Cagr5y	-14.43%
Div CAGR10	-6.13%
Div CAGR3	0%
Div CAGR5	-22.31%
EPS Growth Years	2
EPS Growth5 Y	-5.74
FCF Growth	-21.47%
FCF Growth Q	-32.81%
FCF Growth5 Y	-3.74%
OCF Growth	-15.1%
OCF Growth Q	-18.8%
OCF Growth10 Y	2.9%
OCF Growth5 Y	-2.9%
Revenue Growth	0.89x
Revenue Growth Q	-4.81x
Revenue Growth Years	4x
Revenue Growth3 Y	5.37x
Revenue Growth5 Y	7.29x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.36
Assets	$23.2B
Cash	$809.4M
Current Assets	$6.2B
Current Liabilities	$2.5B
Debt	$11.1B
Debt EBITDA	$5.5
Debt Equity	$1.23
Debt FCF	$12.55
Equity	$9B
Interest Coverage	2.46
Liabilities	$14.1B
Long Term Assets	$17B
Long Term Liabilities	$11.6B
Net Cash	$-10.3B
Net Cash By Market Cap	$-158
Net Debt EBITDA	$5.35
Net Debt Equity	$1.14
Net Debt FCF	$11.64
Tangible Book Value	$-6B
Tangible Book Value Per Share	$-8.75
WACC	6.91

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.47
Inventory Turnover	1.31
Net Working Capital	$3.5B
Quick ratio	0.78
Working Capital	$3.6B
Working Capital Turnover	$2.6

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	$0.14
Dividend Years	1
Dividend Yield	1.76%
Ex Div Date	2025-08-12
Last Dividend	$0.14
Payout Frequency	Annual
Payout Ratio	20.55%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-39.83%
1Y total return	11.89%
200-day SMA	9.15
3Y total return	10.08%
50-day SMA	8.2
50-day SMA vs 200-day SMA	50under200
5Y total return	-54.13%
All Time High	25.73
All Time High Change	-68.6%
All Time High Date	2020-02-21
All Time Low	4.24
All Time Low Change	90.48%
All Time Low Date	2011-11-23
ATR	0.25
Beta	1.17
Ch YTD	-13.58
High	8.19
High52	11.14
High52 Date	2025-07-30
High52ch	-27.47%
Low	7.98
Low52	7.09
Low52 Date	2025-05-09
Low52ch	13.96%
Ma50ch	-1.4%
Premarket Change Percent	1.24
Premarket Price	$8.16
Premarket Volume	7,106
Price vs 200-day SMA	-11.67%
RSI	46.52
RSI Monthly	46.35
RSI Weekly	43.18
Sharpe ratio	0.39x
Sortino ratio	0.74
Total Return	1.76%
Tr YTD	-13.58
Tr1m	-0.25%
Tr1w	-1.82%
Tr3m	-12.93%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	2
Analyst Ratings	Hold
Operating Income	$1.6B
Operating Income Growth	0.83
Operating Income Growth Q	-4.51
Operating Income Growth3 Y	34.49
Operating Income Growth5 Y	8.79
Operating margin	18.58
Price target	$10.15
Price Target Change	$25.62

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	417,315,300%
Float Percent	61.32%
Net Borrowing	-320,769,091.1
Shares Insiders	2.14%
Shares Institutions	46.48%
Shares Out	680,575,163
Shares Qo Q	0%
Short Ratio	7.4
Short Shares	0.4

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$888M
Average Volume	725,067.75x
Bv Per Share	9.25
CAPEX	$-309M
Ch10y	-45.81
Ch1m	-0.25
Ch1w	-1.82
Ch1y	10.38
Ch3m	-12.93
Ch3y	8.6
Ch5y	-55.68
Ch6m	-4.27
Change	0.25%
Change From Open	-0.98
Close	8.06
Days Gap	1.24
Depreciation Amortization	346,713,649.9
Dollar Volume	5,516,636.2
Earnings Date	2022-07-28
Earnings Time	bmo
EBIT	$1.6B
EBITDA	$1.9B
EPS	$0.7
F Score	6
FCF	$888M
FCF EV Yield	4.46x
FCF Per Share	$1.3
Financing CF	-577,654,791
Fiscal Year End	December
Founded	1,940
Graham Number	12.22685
Graham Upside	50.95
Income Tax	$133.7M
Investing CF	-603,020,869
Is Primary Listing	0
Is Spac	No
Last Earnings Date	2022-07-28
Last Report Date	2026-03-31
Last Split Date	2016-01-04
Last Split Type	Forward
Last10k Filing Date	2026-04-17
Lynch Fair Value	$2.96
Lynch Upside	-63.41
Ma150	8.82
Ma150ch	-8.39%
Ma20	8.29
Ma20ch	-2.58%
Net CF	-58,803,182
Open	8.16
Optionable	Yes
P FCF Ratio	7.36
P OCF Ratio	5.55
Payment Date	2025-08-20
Position In Range	47.62
Post Close	8.08
Postmarket Change Percent	0.25
Postmarket Price	$8.1
Ppne	3,730,119,981.8
Pre Close	8.06
Price Date	2026-05-08
Price EBITDA	$3.38
Relative Volume	0.94x
Revenue	8,576,040,583x
Tax By Revenue	1.56x
Tax Rate	18.99%
Tr6m	-4.27%
Volume	682,752
Z Score	1.11

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

GRFS dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.8%

$0.14 annual per share

Payout ratio

+20.6%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

-22.3%

0 consecutive years of growth

Total shareholder yield

+1.8%

Next ex-dividend date: 2025-08-12

Performance

GRFS stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns GRFS?

Insider, institutional, and short-interest positioning.

Institutional ownership

+46.5%

Float: +61.3% of shares outstanding

Insider ownership

+2.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

GRFS momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

46.5

Neutral momentum band

Price vs 200-day MA

-11.7%

50/200-day relationship not available

Beta (5Y)

1.17

Moves roughly with the market

Sharpe ratio

0.39

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About GRFS

Hub-level FAQ points readers to the deeper analysis pages.

What is the current GRFS stock rating?

Grifols, S.A. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full GRFS analysis?

The full report lives at /stocks/GRFS/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for GRFS?

The latest report frames GRFS around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the GRFS page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.